Abstract Purpose: To identify potential prognostic molecular factors in ampullary adenocarcinoma that could be of significant importance. To this end, we examined the possible prognostic significance of cyclooxygenase-2 (Cox-2) and Survivin expression and the apoptotic index in a cohort of uniformly treated patients with ampullary cancer treated with radical surgical excision. Experimental Design: The entry criteria were that the patients have a pathologic diagnosis of ampullary cancer which had been resected. Expression analysis for Cox-2 and Survivin was done by immunohistochemical staining. Apoptotic cells were identified by the terminal deoxyribonucleotidyl transferase^mediated dUTP nick-end labeling (TUNEL) method. Results: Thirty-nine tumor specimens from resected ampullary adenocarcinoma patients were included. By univariate analysis, overall survival was affected by Cox-2 expression and TUNEL staining (respectively, P = 0.0003 and 0.03). Survivin expression did not influence the overall survival in our patient population (P = 0.123). Patients' clinicopathologic features (gender, age, and T and N factors) did not influence outcome. In multivariate Cox regression analysis, Cox-2 expression (relative risk, 4.330; P = 0.005) was the only variable that significantly affected overall survival.
Periampullary neoplasms (usually including extrahepatic bile ducts, pancreatic head, and ampulla of Vater cancers) are significant health problems worldwide and their management represents great challenges for the hepatobiliary specialist. Carcinoma of the ampulla of Vater is a relatively uncommon neoplasm, which accounts for f6% to 7% of periampullary tumors and 0.2% of gastrointestinal tract malignancies (1), with age-standardized incidence rates of 3.8 per 1,000,000 inhabitants in men and 2.7 per 1,000,000 inhabitants in women (2) . Five-year relative survival rates vary from 72.8% in tumor-node-metastasis stage I cancers to 6.6% in tumornode-metastasis stage IV cancers. Most studies report a 5-year survival in 30% to 50% of resected patients (3, 4) . The identification of independent prognostic factors in ampullary tumors has been limited by small numbers of tumor samples and a lack of pathologic review. Furthermore, independently from tumor-node-metastasis stage, any cancer stage includes both long-term survivors and short-term survivors. Literature still show few data on the role of clinical, histopathologic, and molecular factors in predicting length of survival. More specifically, there are only some interesting data that report on the role of allelic loss (loss of heterozygosity) of chromosomes 5q, 17p, and 18q as molecular significant prognostic markers for ampullary cancer patients (5 -7). Achille et al. (5) reported that chromosome 5 allelic losses signify early events in tumors of the papilla of Vater. Moreover, Scarpa et al. (6) evaluated the prognostic role of loss of heterozygosity on chromosomes 17p and 18q in a cohort of 53 ampullary cancers. The authors, by the use of multivariate analysis, showed that chromosome 17p status is an independent prognostic factor in ampullary cancers at the same stage. Finally, Moore et al. (7) analyzed, by genomewide allelotyping on DNA obtained from frozen tissue, a total of 2,976 microsatellites. The resulting allelotype revealed that distinctive chromosomal alterations are present in ampulla of Vater cancers.
There is a need for a better understanding of the biology of ampullary adenocarcinoma, the identification of potential prognostic factors, and clinically relevant molecular targets for therapy. Among the regulators of apoptosis, interest has recently focused on Survivin, a novel, bifunctional member of the inhibitors of apoptosis (IAP) gene family that counteracts cell death and controls mitotic progression. Survivin is a member of the IAP family (endogenous caspase inhibitors), has an antiapoptotic function, and is expressed during human fetal development, but is not detectable in normal adult tissues, except for in the thymus and placenta (8 -10) . Survivin is expressed in most malignant cells, including those of pancreatic, gastric, colonic, lung, breast, prostatic, and bladder cancers, neuroblastomas, and lymphomas (11 -18) . The prognostic role of Survivin in human cancer is still a debatable matter; most data obtained from these studies suggest that Survivin expression in cancer seems to be associated with unfavorable clinicopathologic variables such as poor prognosis with progressive diseases and shorter patient survival rates (11, 12, 14 -17) . However, it must be pointed out that recent publications report a possible favorable prognostic role of the nuclear expression of Survivin in several cancers such as osteosarcoma (19) , breast (16) and gastric (20) cancer, as well as in pediatric ependymomas and choroid plexus tumors (21) . At the moment there is no study of the prognostic role of Survivin in ampullary carcinoma in literature. Cyclooxygenase (Cox) is a rate-limiting enzyme involved in the conversion of arachidonic acid to H 2 -prostaglandin, the precursor of several molecules including prostaglandins, prostacyclins, and thromboxanes. Two Cox genes, Cox-1 and Cox-2, have been identified. Cox-1 is constitutively expressed in many tissues and is involved in several physiologic functions including the cytoprotection of the stomach, vasodilation in the kidney, and the production of a proaggregatory prostanoid, thromboxane, by the platelets. On the other hand, Cox-2 is an inducible gene originally found to be induced by an inflammation or by a variety of other stimuli, such as mitogens, cytokines, and growth factors (22, 23) . Recent studies have stressed the potential role of Cox-2 in carcinogenesis. During recent years, the induction of Cox-2 has been reported in colorectal, gastric, breast, esophagus, and lung carcinomas (24 -28) . There is also strong evidence that Cox-2 overexpression is inversely correlated with the prognosis of several cancers as breast, gastric, lung, cervical, ovarian cancers, and mesothelioma (29 -34) . Moreover, overexpression of Cox-2 has recently been found in various histologic types of pancreatic carcinomas and so suggests that Cox-2 inhibitors could potentially be effective in countering the development and/or progression of human pancreatic carcinoma (35 -37) . Only Kim et al. (38) have investigated the prognostic role of Cox-2 overexpression in ampullary cancer but have not defined its correlation with survival or other clinicopathologic factors. Little is known about the expression and the prognostic role of Cox-2 and Survivin in human ampullary carcinoma. This study is the first in the literature to examine the possible prognostic significance of the expression of Survivin and Cox-2 in relation to the modulation of the apoptotic pathway in a homogeneous cohort of radically resected ampullary cancer patients.
Patients and Methods
Clinical data and tumor specimen acquisition. All patients were consecutively treated at the Catholic University School of Medicine of Rome and at the University Campus Bio-Medico of Rome from January 1986 to April 2003. All patients underwent surgical resection for tumors of ampullary origin and only patients with no residual disease were considered suitable for the study. All patients were staged before surgery by thorax, abdomen, and pelvis computerized tomography scans, by liver palpation and, when indicated, by intraoperative ultrasound of the liver with an aim of excluding the presence of distant metastases. Data on clinical variables, including sex, age, preoperative assessment of disease state, and type of operative procedure, were gathered retrospectively from patient records. Pathologic findings (tumor size and spread and lymph node status) were obtained from the pathologists' original reports. In addition to the original pathology reports, microscopic findings (tumor type, degree of differentiation, and tumor-node-metastasis classification) were reassessed by our pathologists. Tumors were classified in accordance with the International Union Against Cancer variables (39) . Survival was defined as from the date of initial surgery to the date of death or the last contact. Follow-up data were available for all included patients.
Histology. The formalin-fixed, paraffin-embedded samples were sectioned at 5 Am and stained with H&E. The histologic diagnosis were reexamined by two independent pathologists. In addition, the most representative blocks of each patient were selected to be cut into new 5-Am-thick sections for immunohistochemical studies.
Immunohistochemistry and quantification of the immunoreactivity. Immunohistochemical studies were done on 5-mm sections by the streptavidin-biotin-peroxidase system using a commercial kit (UCS Diagnostic, West Logan, UT) in accordance with the instructions of the manufacturer. In brief, sections were deparaffinized and antigen retrieval was achieved by steaming slides for 35 minutes. Endogenous peroxidase was blocked using 3% H 2 O 2 solution in PBS for 5 minutes. The following primary antibodies were used: rabbit polyclonal antiSurvivin (ABcam, Cambridge, United Kingdom), goat polyclonal antiCox-2 (Santa Cruz Biotechnologies, Santa Cruz, CA). Sections were counterstainded with hematoxylin and mounted. The primary antibody was replaced with rabbit or goat preimmune serum as a negative control for nonspecific staining. The stained sections were observed using a light microscope, and positivity was determined by cell staining. Antigens were then quantified according to the following two variables: (a) the number of positively stained cells and (b) the intensity of the staining, ranging from pale pink to dark orange.
The Cox-2 and Survivin positivities were graded on the basis of the intensity and the number of positive cells: 0, negative; +1, weak to moderate positive affecting less than 50% of the tumor area; +2, weak to moderate positive on the majority of the tumor or strong positive in the minority of the tumor; and +3, strong positive in the majority of the tumor area. The specimens with a grade of more than +1 were regarded as positive, and 0 grade as negative. These scorings were done in a blinded fashion.
Detection of apoptosis. Apoptotic cells were identified by the terminal deoxyribonucleotidyl transferase -mediated dUTP nick-end labeling (TUNEL) method. Dewaxed and rehydrated specimens were incubated in 40 Ag/mL proteinase K for 1 hour at 37jC and were treated with 3% H 2 O 2 in methanol for 30 minutes at room temperature. After adding an equilibration buffer for 5 minutes at room temperature, terminal deoxynucleotidyl transferase enzyme was pipetted onto the sections and incubated at 37jC for 2 hours. The reaction was stopped by incubating the sections in stop buffer for 30 minutes at 37jC. The biotinylated dUTP molecules incorporated into nuclear DNA were made visible by incubation with horseradish peroxidase -conjugated streptavidin (Dako, Glostrup, Denmark) diluted 1:100 at 37jC for 30 minutes in a moist chamber. After further rinsing of the sections in PBS thrice for 5 minutes, the peroxidase coloring reaction was done by immersing the sections for 5 minutes in 0.05 mol/L Tris-HCl buffer (pH 7.4), containing 30 mg/dL diaminobenzidine tetrahydrochloride, 65 mg/dL sodium azide, 10 mmol/L imidazole, and 0.005% H 2 O 2 . The nuclei were counterstained with 5% Mayer's hematoxylin buffered with 0.1 mol/L veronal acetate (pH 4.0) for 10 seconds. A specimen known to be positive for apoptotic cells was used as the positive control for subsequent staining. For the negative control, terminal deoxynucleotidyl transferase was replaced with distilled water. The sections were counterstained with hematoxylin. A total of 500 cells were counted in each specimen. The apoptotic index was defined as follows: apoptotic index (%) = 100 Â apoptotic cells/ total cells. We stratified tumor specimens according to TUNEL staining in <10% or >10% stained cells.
Statistical analysis. A univariate survival analysis for each prognostic variable on overall survival was estimated as by the Kaplan-Meier method (40) . The terminal event was death, attributable to cancer or noncancer causes. The statistical significance of the differences in survival distribution among the prognostic groups was evaluated by the log-rank test (41) . The Cox proportional hazards model was applied to the multivariate survival analysis (42) . The prognostic variables on overall survival included age, gender, T and N factors, TUNEL staining, cytoplasmic Survivin expression, and cox-2 expression. P < 0.05 was regarded as statistically significant in two-tailed tests. SPSS software (version 10.00, SPSS, Chicago, IL) was used for statistical analysis.
Results
Patient characteristics. The cohort of patients (Table 1) consisted of 39 patients with pathologic diagnosis of ampullary cancer (20 men and 19 women) undergoing pancreaticoduodenectomy. The median age at diagnosis was 62.3 years (range 38-78). The main histopathologic tumor features are summarized in Table 1 . The median duration of follow-up after surgery was 51 months (range 13-102). The median overall survival was 46 months (range 6-100) and the 1-, 3-, and 5-year overall survivals were 89.7%, 28.2% and 25.5%, respectively. After a median follow-up of 51 months, 24 patients (61.5%) are still alive without evidence of disease, 2 patients (5.1%) are alive with recurrence of disease, and 13 patients (33.4%) are dead (9 patients died of ampullary carcinoma). Adjuvant radiotherapy and/or chemotherapy for ampullary cancer was not routinely offered in the hospitals involved in the study.
Cox-2, Survivin, and TUNEL staining. Table 2 summarizes the results from the immunohistochemical analysis of 39 ampullary carcinoma specimens from radically resected patients. The expression analysis of Cox-2 revealed that in 24 of 39 (61.5%) specimens Cox-2 staining was positive (Fig. 1A) . Cox-2 expression was always cytoplasmic. TUNEL staining was present in more than 10% of the observed cancer cells in 24 ampullary cancer specimens (61.5%; Fig. 1B) . Moreover, the expression analysis of Survivin revealed that in 36 of 39 (92.3%) specimens no nuclear expression was recorded (data not shown), whereas in 16 (41.0%) specimens the cytoplasmic staining for Survivin was positive (Fig. 1C) (Table 3) . Moreover, between the molecular factors analyzed, only Cox-2 expression and TUNEL staining seemed to influence overall survival. In particular, those patients with overexpression of Cox-2 showed a shorter overall survival (P = 0.0003) and those with high TUNEL staining showed a longer survival (P = 0.03; Table 3 ). The median survival time in patients with high Cox-2 expression was only 16 versus 73 months in those with low Cox-2 expression. The median survival time in patients with high apoptotic index, evaluated by TUNEL method, was 122 versus 44 months in those with low apoptotic index ( Table 3 ). The Kaplan-Meier method was used to examine the effect of Survivin and Cox-2 overexpression and of high apoptotic index evaluated by TUNEL method on overall survival in patients radically resected for an ampullary cancer. The Kaplan-Meier survival plots for all patients showed a statistically significant association between either a low apoptotic index (Fig. 2) or low Cox-2 expression (Fig. 3 ) and better outcome (P = 0.03 and 0.0003, respectively), whereas Survivin levels (Fig. 4) The results of the multivariate survival analysis are given in Table 4 . All variables that reached significance in the univariate survival analysis were incorporated in the multivariate analysis, with disease-related survival used as primary end point. In this model, only Cox-2 expression was defined as an independent prognostic factor. The calculated relative risk of death in ampullary cancer patients with high Cox-2 expression was significantly higher (relative risk, 4.330; P = 0.005). The other immunohistochemical variables associated with prognosis in univariate analysis (TUNEL staining) did not influence overall survival when evaluated by multivariate analysis as single prognostic factors (relative risk, 1.989; P = 0.201).
Discussion
There are few substantial data reporting significant prognostic markers for ampullary cancer patients. The influence of pathologic (tumor size, lymph node involvement, status of resection margins, and perineural invasion), surgical (aggressive surgical approach versus limited resection), and biological (p53, c-erbB2, bax-2, and apoptotic index) factors is inconclusive (43 -47) . An increasing interest is now focused on molecular markers to select patients with better prognosis and, therefore, in need of more aggressive treatments. (49) . This data is supported by the observation that both lymph node metastasis and histologically detectable angioinvasion are correlated with increased expression of Cox-2 in several kinds of cancers (50, 51) .
Other factors which showed to be involved in Cox-2 -related pathways are induction of angiogenesis (52), suppression of apoptosis (53, 54) , and suppression of antitumor immunity (55) . The results of the present article provide evidence that Cox-2 may represent a significant prognostic factor in radically resected ampullary cancer patients. Knowledge of the factors with an independent prognostic power is crucial for the development and interpretation of prospective randomized trials in which patients are stratified according to these prognostic determinants. Preclinical animal model studies in several neoplasms have shown tumor reduction when animals are treated with either nonspecific or specific inhibitors of 57) . These studies propose that nonsteroidal antiinflammatory drugs may act on multiple tumor-progression targets via both Cox-2 -dependent and -independent pathways. The present study suggests a possible role of Cox-2 inhibitors in the prevention or therapy of ampullary carcinoma. 
